Ratings by Cantor Fitzgerald (Kyle Mikson)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/1/2021 Brainsway BWAY Maintain Overweight
(N/A)
 
 
  Details
3/30/2021 PAVmed PAVM New Coverage Overweight
(N/A)
4.17
(6.41)
53.72% Details
3/17/2021 Exagen XGN Maintain Overweight
(N/A)
 
 
  Details
3/10/2021 VolitionRX VNRX New Coverage Overweight
(N/A)
3.84
(3.23)
-15.89% Details
1/29/2021 Aspira Women's Heath AWH New Coverage Overweight
(N/A)
8.21
(5.64)
-31.3% Details
1/29/2021 icad Inc. ICAD New Coverage Overweight
(N/A)
15.00
(18.21)
21.4% Details
1/27/2021 Brainsway BWAY Maintain Overweight
(N/A)
 
 
  Details
1/19/2021 Exagen XGN Maintain Overweight
(N/A)
 
 
  Details
1/12/2021 Pacific Biosciences of California PACB Maintain Overweight
(N/A)
 
 
  Details
7/14/2020 Brainsway BWAY New Coverage Overweight
(N/A)
5.73
(10.53)
83.77% Details
6/12/2020 Pacific Biosciences of California PACB Maintain Overweight
(N/A)
 
 
  Details
6/10/2020 Pacific Biosciences of California PACB Maintain Overweight
(N/A)
 
 
  Details
6/2/2020 Exagen XGN New Coverage Overweight
(N/A)
11.59
(15.63)
34.86% Details
6/2/2020 Pacific Biosciences of California PACB New Coverage Overweight
(N/A)
3.52
(29.15)
728.13% Details